Clare Wilson is a UK-based science and health journalist currently writing for The i Paper, with previous bylines in New Scientist. Her work focuses on translating complex medical research into public-facing narratives, particularly those with implications for healthcare systems and policy.
Clare Wilson has carved a unique niche as a science journalist who bridges complex medical research and accessible public education. Her career began at New Scientist, where she honed her ability to translate cutting-edge studies into compelling narratives. This foundation led to her current role at The i Paper, where her weekly newsletter "Everyday Science" reaches a broad audience with topics ranging from cancer screening to neurological breakthroughs.
This groundbreaking piece for New Scientist explores Cilcare’s research into neurotrophin-stimulating drugs, challenging the notion that hearing damage is irreversible. Wilson meticulously explains how these compounds could repair cochlear synapses, citing interviews with biotech researchers and audiologists. The article’s impact is evident in its citation by medical institutions and patient advocacy groups.
In this personal yet analytical newsletter edition, Wilson reflects on receiving NHS screening invitations while interviewing epidemiologists about early-detection technologies. She balances statistical analysis (e.g., 30% reduction in cervical cancer mortality from routine screenings) with human stories about diagnostic accessibility.
This forward-looking analysis covers emerging therapies for Alzheimer’s and PTSD, emphasizing non-invasive neuromodulation techniques. Wilson highlights a UK clinical trial using focused ultrasound to enhance drug delivery across the blood-brain barrier, contextualizing it within broader trends in neurotech investment.
Wilson consistently frames scientific discoveries through the lens of real-world impact. A successful pitch might explore how AI diagnostics reduce NHS waiting times or how wearable tech democratizes health monitoring. For example, her cancer screening article emphasized how early detection algorithms could alleviate strain on healthcare systems.
While she covers global research, Wilson prioritizes British institutions and startups. Recent pieces have featured work from the Francis Crick Institute and University College London. Pitches should emphasize collaborations with NHS trusts or UKRI-funded projects, like her coverage of Manchester-based hearing regeneration studies.
Her tinnitus article successfully merged biotech, neuroscience, and social policy by examining how hearing loss exacerbates economic inequalities. Pitches intersecting multiple fields—such as climate change’s impact on disease vectors or fintech solutions for medical billing—align with this approach.
"Wilson’s work exemplifies science journalism that empowers readers to engage with complex topics without oversimplification." – Association of British Science Writers
As an award-winning reporter, Wilson has been recognized by the ABSW for her ability to make specialized research accessible. Her New Scientist investigation into pandemic-era clinical trial delays received commendation for its rigorous analysis of biopharma supply chain data.
At PressContact, we aim to help you discover the most relevant journalists for your PR efforts. If you're looking to pitch to more journalists who write on Science, here are some other real estate journalist profiles you may find relevant:
